Burlington Researcher Awarded American Lung Association Grant to Study the Development of Lung Cancer and New Treatments for Chemo-resistant Tumors

Lung health research is more important than ever. Never have we faced so many challenges to our lung health, including COVID-19, vaping and smoke from increased wildfires. Today, the American Lung Association in Vermont announced that Yvonne Janssen-Heininger, Ph.D. from the University of Vermont was awarded the Lung Cancer Discovery Award.

“Vermont ranks average when it comes to rates of new cases of lung cancer, lack of treatment, and surgery. When it comes to treating the leading cause of cancer deaths in the state, Vermont can do better. We also have more than 85,000 people in our state are living with chronic lung disease,” said Trevor Summerfield, Director of Advocacy at the Lung Association in Vermont. “We are excited for Yvonne to join the American Lung Association Research Team to help improve lung health here in Vermont and across the nation.” 

Yvonne Janssen-Heininger, Ph.D., is an expert in the fields of pulmonary fibrosis and redox medicine. Growing up in the south of Holland, she witnessed abundant chronic lung diseases in her community, including her family. Coal mining was prevalent in the Netherlands through the 1970s, and air pollution and tobacco smoking remain the leading causes of diseases including pneumoconiosis, silicosis, pulmonary fibrosis and lung cancer. The experience triggered Janssen-Heininger’s ambition to unravel the molecular mysteries of pulmonary diseases and discover potential treatments.

Janssen-Heininger’s Lung Association grant will fund a project seeking to study protein oxidation in the development of lung cancer with the aim of creating a new druggable target for chemotherapy-resistant tumors.  She said, “The goal is to be able to interfere with this protein oxidation pathway, focusing on a specific target, in order to destroy lung tumors and to cause cancers to respond much better to cisplatin [chemotherapy], at lower doses. Ultimately, we hope this study will lead to improved response to immunotherapy.”

In the 2022-2023 grants cycle, the Lung Association is funding $13.2 million for more than 130 lung health research grants. For this round of funding, the organization placed a greater focus on strategic partnerships with key organizations like American Thoracic Society and CHEST, and grants that focus on equity like the Harold Amos Scholar.

Research projects funded by the Lung Association are carefully selected through rigorous scientific review and awardees represent the investigation of a wide range of complex issues. Awards were given in eight different categories; ALA/AAAAI Allergic Respiratory Diseases Award, ALA/ATS/CHEST Foundation Respiratory Health Equity Research Award, Catalyst Award, COVID-19 Respiratory Virus Research Award, Dalsemer Award, Innovation Award, Lung Cancer Discovery Award, and Public Policy Research Award. 

The Lung Association’s Nationwide Research Program includes the Awards and Grants Program, and also our Airways Clinical Research Network, the nation's largest not-for-profit network of clinical research centers dedicated to asthma and COPD treatment research.

For more information about the new grant awardees and the entire American Lung Association Research Team, visit Lung.org/research-team.

For more information, contact:

Jennifer Solomon
(516) 680-8927
[email protected]

Freedom From Smoking Clinic
, | May 29, 2024
Asthma Basics Workshop - National
, | Jun 18, 2024